节点文献

同步放化疗治疗中晚期宫颈癌的临床研究

Clinical analysis of taxol plus cisplatin concurrent with radiotherapy for middle and advanced cervical cancer

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 杨栓雀雷磊王玉珍赵西侠

【Author】 YANG Shuan-que,LEI Lei,WANG Yu-zhen,ZHAO Xi-xia Department of Gynecology Oncoloy,Shaanxi Province Tumor Hospital,Xi’an 710061,China

【机构】 陕西省肿瘤医院妇瘤科陕西省肿瘤医院妇瘤科 陕西西安710061陕西西安710061

【摘要】 目的:观察同步放化疗治疗中晚期宫颈癌的疗效及安全性。方法:将2004年6月~2006年6月我院收住的Ⅱb~Ⅲb期宫颈癌患者77例,随机分为同步放化疗组37例(放化组)和单纯放疗组(单放组)40例,两组放疗方案相同,放化组于第1第4周予以TP方案化疗1周期。结果:同步放化疗组近期有效率(CR+PR)97.2%,单纯放疗组77.5%。两组比较差异有显著性意义(P<0.05),放化疗组白细胞下降,恶心、呕吐、脱发较单放组明显,差异有显著意义(P<0.05)。结论:传统放疗加TP方案同步化疗可提高中晚期宫颈癌的近期疗效,其毒副反应较单纯放疗增加,但不影响放疗进程,患者能耐受。

【Abstract】 Objective:To evaluate the efficacy and safety of taxol plus cisplantin concurrent with radiotherapy for middle and advanced cevvical carcinoma.Methods:From June 2004 to June 2006,77 patients with advanced stage Ⅱb~Ⅲb cervcal cancer were divided randomly into chemeradiotherapy group(37 cases) and radiotherapy alone group(40 cases),patients of chemoradiation group were given chemotherapy in the first week and the fourth week,All patients underwent the same radiotherapy.Results:effective rate was 97.2%in the former group and 77.5% in the latter.There was significant difference in effective rate between the two groups(P<0.05)The leucopenia,nausea and vomiting,hair-falled in chemoradiotherapy group were apparent but tolerable.Conclusion:Concurrent chemoradiotherapy with taxol plus cisplatin for middle and advanced cervical cancer can improve the curative effect,side effects are tolerable,and doesn`t affect radiotherapy cause.

  • 【文献出处】 现代肿瘤医学 ,Journal of Modern Oncology , 编辑部邮箱 ,2007年10期
  • 【分类号】R737.33
  • 【被引频次】5
  • 【下载频次】106
节点文献中: 

本文链接的文献网络图示:

本文的引文网络